TY - JOUR
T1 - Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice
AU - Safar, Jiri G.
AU - Scott, Michael
AU - Monaghan, Jeff
AU - Deering, Camille
AU - Didorenko, Svetlana
AU - Vergara, Julie
AU - Ball, Haydn
AU - Legname, Giuseppe
AU - Leclerc, Estelle
AU - Solforosi, Laura
AU - Serban, Hana
AU - Groth, Darlene
AU - Burton, Dennis R.
AU - Prusiner, Stanley B.
AU - Williamson, R. Anthony
N1 - Funding Information:
Acknowledgments The authors thank Elizabeth Williams (Wyoming State Veterinary Laboratory, University of Wyoming, Laramie) for providing the CWD samples, Hank Baron and Fred Feldman for encouragement and stimulating discussions, and the British Ministry of Agriculture, Fisheries and Food (MAFF) and VLA (UK) for supplying BSE brainstems. This work was supported by grants from the National Institutes of Health (AG02132, AG010770, NS22786, and NS14069) and MAFF (ES1756), as well as by gifts from the G. Harold and Leila Y. Mathers Charitable Foundation and from Centeon.
PY - 2002/11
Y1 - 2002/11
N2 - There is increasing concern over the extent to which bovine spongiform encephalopathy (BSE) prions have been transmitted to humans, as a result of the rising number of variant Creutzfeldt-Jakob disease (vCJD) cases. Toward preventing new transmissions, diagnostic tests for prions in livestock have been developed using the conformation-dependent immunoassay (CDI), which simultaneously measures specific antibody binding to denatured and native forms of the prion protein (PrP). We employed high-affinity recombinant antibody fragments (recFab) reacting with residues 95-105 of bovine (Bo) PrP for detection and another recFab that recognizes residues 132-156 for capture in the CDI. We report that the CDI is capable of measuring the disease-causing PrP isoform (PrPSc) in bovine brainstems with a sensitivity similar to that of end-point titrations in transgenic (Tg) mice expressing BoPrP. Prion titers were ∼107 ID50 units per gram of bovine brainstem when measured in Tg(BoPrP) mice, a figure ∼10 times greater than that determined by bioassay in cattle and ∼10, 000x greater than in wild-type mice. We also report substantial differences in BoPrPSc levels in different areas of the obex region, where neuropathology has been consistently observed in cattle with BSE. The CDI was able to discriminate between PrPSc from BSE-infected cattle and Tg(BoPrP) mice as well as from chronic wasting disease (CWD)-infected deer and elk. Our findings argue that applying the CDI to livestock should considerably reduce human exposure to animal prions.
AB - There is increasing concern over the extent to which bovine spongiform encephalopathy (BSE) prions have been transmitted to humans, as a result of the rising number of variant Creutzfeldt-Jakob disease (vCJD) cases. Toward preventing new transmissions, diagnostic tests for prions in livestock have been developed using the conformation-dependent immunoassay (CDI), which simultaneously measures specific antibody binding to denatured and native forms of the prion protein (PrP). We employed high-affinity recombinant antibody fragments (recFab) reacting with residues 95-105 of bovine (Bo) PrP for detection and another recFab that recognizes residues 132-156 for capture in the CDI. We report that the CDI is capable of measuring the disease-causing PrP isoform (PrPSc) in bovine brainstems with a sensitivity similar to that of end-point titrations in transgenic (Tg) mice expressing BoPrP. Prion titers were ∼107 ID50 units per gram of bovine brainstem when measured in Tg(BoPrP) mice, a figure ∼10 times greater than that determined by bioassay in cattle and ∼10, 000x greater than in wild-type mice. We also report substantial differences in BoPrPSc levels in different areas of the obex region, where neuropathology has been consistently observed in cattle with BSE. The CDI was able to discriminate between PrPSc from BSE-infected cattle and Tg(BoPrP) mice as well as from chronic wasting disease (CWD)-infected deer and elk. Our findings argue that applying the CDI to livestock should considerably reduce human exposure to animal prions.
UR - http://www.scopus.com/inward/record.url?scp=0036843448&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036843448&partnerID=8YFLogxK
U2 - 10.1038/nbt748
DO - 10.1038/nbt748
M3 - Article
C2 - 12389035
AN - SCOPUS:0036843448
SN - 1087-0156
VL - 20
SP - 1147
EP - 1150
JO - Nature biotechnology
JF - Nature biotechnology
IS - 11
ER -